-
HLA-DQB1 codon 57 is critical for peptide binding and recognition.
The Journal of Experimental MedicineKwok WW, Domeier ME, Johnson ML, Nepom GT, Koelle DM -
Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis.
The Journal of Rheumatology. SupplementNepom GT, Gersuk V, Nepom BS -
Polyglot and polymorphism. An HLA update.
Arthritis and RheumatismNepom BS, Nepom GT -
Glutamic acid decarboxylase and other autoantigens in IDDM.
Current Opinion in ImmunologyNepom GT -
Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1.
Molecular and Cellular BiologyBeaty JS, West KA, Nepom GT -
HLA-DQ polymorphisms are highly selective for peptide binding interactions.
Journal of ImmunologyKwok WW, Nepom GT, Raymond FC -
Ultrastructural allelic variation in HLA-DQB1 promoter elements.
Human ImmunologyLeech N, Sorrentino R, McCulloch DK, Nepom GT -
Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.
The Journal of Clinical InvestigationKovats S, Nepom GT, Coleman M, Nepom BS, Kwok WW, Blum JS -
The prevention of IDDM. Injecting insulin into the cytokine network.
DiabetesGladstone P, Nepom GT -
Defective CD4+ T-lymphocyte reconstitution in major histocompatibility complex class II-deficient transplant models.
BloodHuss R, Nepom GT, Deeg HJ -
Differential transcription elements direct expression of HLA-DQ genes.
Clinical Immunology and ImmunopathologyWoolfrey AE, Nepom GT -
Genetic and immunological markers of insulin dependent diabetes in Black Americans.
AutoimmunityLeech NJ, Kitabchi AE, Gaur LK, Hagopian WA, Hansen J, Burghen GA, Palmer JP, Nepom GT -
Differential expression of HLA-DQB1 alleles in a heterozygous cell line.
ImmunogeneticsNepom GT, Chung J, West KA -
Class II antigens and disease susceptibility.
Annual Review of MedicineNepom GT -
Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity, immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors.
Journal of Immunotherapy with Emphasis on Tumor ImmunologyHock RA, Reynolds BD, Tucker-McClung CL, Kwok WW
